CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 65 filers reported holding CORVUS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.87 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $35,614 | +223.8% | 15,552 | +135.6% | 0.00% | – |
| Q1 2022 | $11,000 | -80.4% | 6,600 | -71.6% | 0.00% | -100.0% |
| Q4 2021 | $56,000 | -42.3% | 23,245 | +15.9% | 0.00% | 0.0% |
| Q3 2021 | $97,000 | +212.9% | 20,052 | +947.6% | 0.00% | -50.0% |
| Q3 2017 | $31,000 | +3.3% | 1,914 | +33.9% | 0.00% | 0.0% |
| Q1 2017 | $30,000 | +275.0% | 1,429 | +170.6% | 0.00% | +100.0% |
| Q4 2016 | $8,000 | – | 528 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 3,101,709 | $7,475,000 | 1.50% |
| ADAMS STREET PARTNERS LLC | 3,275,616 | $7,894,000 | 1.20% |
| Telemetry Investments, L.L.C. | 192,909 | $465,000 | 0.60% |
| CHI Advisors LLC | 400,000 | $964,000 | 0.32% |
| Orbimed Advisors | 6,943,654 | $16,734,000 | 0.22% |
| Ikarian Capital, LLC | 482,610 | $1,163,000 | 0.17% |
| Anson Funds Management LP | 528,358 | $1,273,000 | 0.12% |
| BVF INC/IL | 1,370,947 | $3,304,000 | 0.12% |
| VR Adviser, LLC | 250,000 | $603,000 | 0.08% |
| PURA VIDA INVESTMENTS, LLC | 492,384 | $1,187,000 | 0.04% |